Jones Financial Companies
LGND icon

Jones Financial Companies’s Ligand Pharmaceuticals LGND Stock Holding History

Jones Financial Companies’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$806K Buy
2,656
+1,522
+134% +$359K ﹤0.01% 2002
2026
Q1 		$222K Buy
1,134
+1,071
+1,700% +$212K ﹤0.01% 2359
2025
Q4 		$11.9K Hold
63
– – ﹤0.01% 3141
2025
Q3 		$10.7K Buy
63
+25
+66% +$3.72K ﹤0.01% 3056
2025
Q2 		$4.34K Buy
38
+4
+12% +$428 ﹤0.01% 3183
2025
Q1 		$3.66K Buy
34
+30
+750% +$3.39K ﹤0.01% 3059
2024
Q4 		$429 Buy
+4
New +$452 ﹤0.01% 3247
2024
Q3 		– Sell
-220
Closed -$18.5K – 3079
2024
Q2 		$18.5K Buy
+220
New +$17.5K ﹤0.01% 1562

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jones Financial Companies's LGND Position: Q2 2026 in Review

Jones Financial Companies increased its Ligand Pharmaceuticals (LGND) stake by 134% in Q2 2026, buying an estimated $359K and bringing the position to 2,656 shares worth $806K. The position accounts for ﹤0.01% of the portfolio, ranked #2002.

Jones Financial Companies first reported a position in LGND in Q2 2024 and has held it in 8 quarters since. 414 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • Jones Financial Companies held 2,656 shares of Ligand Pharmaceuticals worth $806K as of Q2 2026.
  • Jones Financial Companies bought 1,522 Ligand Pharmaceuticals shares in Q2 2026, an estimated $359K.
  • Ligand Pharmaceuticals made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #2002 holding.
  • Jones Financial Companies first reported a position in Ligand Pharmaceuticals in Q2 2024 and has held it in 8 quarters since.
  • 414 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.